(Q34398109)

1 August 2017

Moclobemide excretion in human breast milk (English)

1 reference

1 August 2017

Pons G

1

1 reference

1 August 2017

Schoerlin MP

2

1 reference

1 August 2017

Tam YK

3

1 reference

1 August 2017

Moran C

4

1 reference

1 August 2017

Pfefen JP

5

1 reference

1 August 2017

Francoual C

6

1 reference

1 August 2017

Pedarriosse AM

7

1 reference

1 August 2017

Chavinie J

8

1 reference

1 August 2017

Olive G

9

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 1990

1 reference

British Journal of Clinical Pharmacology

1 August 2017

1 reference

1 August 2017

29

1 reference

1 August 2017

27-31

1 reference

1 August 2017

1

1 reference

Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380057

Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380057

Estimation of variance for harmonic mean half-lives.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380057

Disposition kinetics of moclobemide, a monoamine oxidase-A enzyme inhibitor: single and multiple dosing in normal subjects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380057

Short-acting novel MAO inhibitors: in vitro evidence for the reversibility of MAO inhibition by moclobemide and Ro 16-6491.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380057

Pharmacokinetics and metabolism of reversible MAO-A inhibitors in the human

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380057

Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380057

A Placebo-controlled Study of the Antidepressant Activity of Moclobemide,A New MAO-A Inhibitor

6 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2297459

12 December 2020

inferred from PubMed ID database lookup

A controlled study of a specific MAO A reversible inhibitor (R011-1163) and amitriptyline in depressive illness

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2297459

12 December 2020

inferred from PubMed ID database lookup

Determination of the new monoamine oxidase inhibitor moclobemide and three of its metabolites in biological fluids by high-performance liquid chromatography

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2297459

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1111/J.1365-2125.1990.TB03598.X

1 reference

release_vbu2rzhzinambj76ajjemslbo4

1 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vbu2rzhzinambj76ajjemslbo4

24 November 2022

mapped directly with Wikidata item

PMCID

1380057

1 reference

1 August 2017

1 reference